Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 736.25 INR
Change Today +12.05 / 1.66%
Volume 177.6K
IPCA On Other Exchanges
Natl India
As of 7:05 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

ipca laboratories ltd (IPCA) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/19/15 - 888.00
52 Week Low
02/9/15 - 591.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IPCA LABORATORIES LTD (IPCA)

Related News

No related news articles were found.

ipca laboratories ltd (IPCA) Related Businessweek News

No Related Businessweek News Found

ipca laboratories ltd (IPCA) Details

Ipca Laboratories Limited manufactures and supplies pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments primarily in India. The company offers APIs in therapeutic areas of anti-malarial, anti-hypertensive, diuretic, anthelmintic, and non steroidal anti-inflammatory drugs. It also provides generic and branded formulations in various dosage forms, such as oral solids and liquids, dry powders for suspension, and liquid and dry injectables. The company provides formulations for cardiovascular, anti-diabetic, cardio-diabetic, rheumatology, orthopedics, pain management, dermatology, gastro-intestinal, anti-bacterial, respiratory, neuropsychiatry, anti-malarial, anti-pyretic, cough, non-steroidal anti-inflammatory drugs, anti-infective, nutraceutical, urology, and geriatric areas, as well as oral and injectable antibiotics surgical and non-surgical needs. In addition, it offers drug intermediates. The company also exports its products to approximately 120 countries worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.

5,051 Employees
Last Reported Date: 05/30/09
Founded in 1949

ipca laboratories ltd (IPCA) Top Compensated Officers

Chairman, Chief Executive Officer, Managing D...
Total Annual Compensation: 33.0M
Chief Financial Officer, Joint Managing Direc...
Total Annual Compensation: 9.7M
President of APIs & Generics, Executive Direc...
Total Annual Compensation: 6.0M
President of Medical Affairs & Clinical Resea...
Total Annual Compensation: --
President of Generics
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

ipca laboratories ltd (IPCA) Key Developments

Ipca Laboratories Limited Approves Dividend for the Year Ended March 31, 2015; Approves Adoption of New Set of Articles of Association

Ipca Laboratories Limited announced at the AGM held on July 30, 2015 has approved a dividend on equity shares of INR 1 per share (50%) for the year ended March 31, 2015. The company has also approved the adoption of new set of articles of association of the company.

Ipca Laboratories Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Ipca Laboratories Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net profit for the period of INR 188.9 million compared to INR 1,367.4 million a year ago. Net sales/income from operations (net of excise duty) was INR 7,509.8 million compared to INR 9,282.0 million a year ago. Profit from operations before other income, foreign exchange transactions, finance costs and exceptional items was INR 400.8 million compared to INR 1,797.5 million a year ago. Profit from ordinary activities before tax was INR 271.3 million compared to INR 1,825.8 million a year ago. Basic and diluted earnings per share were INR 1.50 compared to INR 10.84 a year ago. EBITDA was INR 821.8 million compared to INR 2,309.2 million a year ago.

Ipca Laboratories Limited, Q1 2016 Earnings Call, Jul 31, 2015

Ipca Laboratories Limited, Q1 2016 Earnings Call, Jul 31, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPCA:IN 736.25 INR +12.05

IPCA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cadila Healthcare Ltd 419.40 INR +12.30
Cipla Ltd/India 679.05 INR +2.70
Dr Reddy's Laboratories Ltd 4,228 INR +40.55
Torrent Pharmaceuticals Ltd 1,509 INR -19.30
Wockhardt Ltd 1,539 INR -15.45
View Industry Companies

Industry Analysis


Industry Average

Valuation IPCA Industry Range
Price/Earnings 22.6x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 13.2x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IPCA LABORATORIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at